Astrocytes are glial cells that play critical roles in maintaining central nervous system (CNS) homeostasis. Their functions include preserving the blood–brain barrier, supplying nutrients to neurons, regulating extracellular ion balance, and modulating neurotransmission.
In response to CNS injury, infection, or disease, activated microglia release pro-inflammatory cytokines that trigger astrocyte reactivity. These reactive astrocytes lose neuroprotective properties and gain neurotoxic functions, by releasing saturated lipids (Figure 1).
Neurotoxic astrocytes contribute to chronic neuroinflammation—a hallmark of many neurodegenerative diseases—and can exacerbate neuronal damage and disease progression. Modelling this process in vitro provides a powerful tool to test candidate drugs for anti-inflammatory and neuroprotective activity.
Astrocytic activation is both a consequence and a driver of chronic neuroinflammation in neurodegenerative diseases. Reactive astrocytes perpetuate the cycle of neurotoxicity, exacerbating neuronal damage in conditions such as Alzheimer’s and Parkinson’s disease.
This assay reliably models astrocyte polarization in both rodent and human systems, providing a robust platform for testing compounds with potential anti-inflammatory or neuroprotective effects.